Vasodilators

CAS: 1333-82-0 EC No: 215-607-8 MDL No: MFCD00010952 RTECS: GB6650000 UN No: UN1463 Haz Class: 5.1 (6.1,8) Packing Group: II Crystalline Molecular Formula: CrO₃ MW: 99.99 Melting Point: 196&deg (decomposes) Density (g/mL): 2.7

Chromone-3-carboxylic acid is a chromone derivative. Its potential as an antioxidant in charge transfer (CT) processes has been assessed by surface-enhanced Raman scattering (SERS) analysis of chromone 3-carboxylic acid adsorbed on silver colloids.

Chromozym &#174 TH is a chromophoric substrate mostly used to detect thrombin activity † Tosyl-Gly-Pro-Arg-4-nitranilide acetate Application Use Chromozym &#174 TH as a substrate for the determination of serine proteases, specifically thrombin

Cibenzoline also called (±)-2-(2,2-diphenylcyclopropyl)-2-imidazoline succinate, is generally used in stereo combination of R(+) and S(&#8722) forms. It also exhibits anticholinergic activity.

Cibenzoline also called (±)-2-(2,2-diphenylcyclopropyl)-2-imidazoline succinate, is generally used in stereo combination of R(+) and S(&#8722) forms. It also exhibits anticholinergic activity.

A potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective PPAR&#947 agonist (EC 50 = 3 &#181M). A potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective peroxisome proliferator-activated receptor &#947

Biochem/physiol Actions PDE3 catalyzes the phosphodiester bond hydrolysis, observed in secondory messengers such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Inhibitors of PDE3 are generally inotropic and

A cell-permeable selective inhibitor of cGMP-inhibited phosphodiesterase (PDE III IC 50 = 70 nM). Biochem/physiol Actions Cell permeable: yes Primary Target PDE 3 Product does not compete with ATP.

Cilostazol is a potent cyclic nucleotide phosphodiesterase inhibitor. It is mainly used as antiplatelet agent.

Cilostazol prevents platelet aggregation and has vasodilatory properties. It is used to treat chronic arterial disease and intermittent claudication.

Cilostazol prevents platelet aggregation and has vasodilatory properties. It is used to treat chronic arterial disease and intermittent claudication.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the